Production facilities

Akrikhin manufacturers its products at its more than 40 000 square meters production site located 20 km from Moscow in Staraya Kupavna. The production complex consists of in several workshops which manufacture solid finished forms (tablets, capsules) and soft and liquid finished forms (ointments, gels, creams, syrups, etc).

Akrikhin is in TOP-5 largest Russian pharmaceutical producers in terms of volume of the produced goods. The production output was equal to more than 60 mln packs. Thus every 20th medicine pack produced in the Russian Federation is produced at Akrikhin production facility.

Akrikhin Staraya Kupavna production facility also features 12 thousand square meters of warehousing.

In 2016 AKRIKHIN has implemented a large-scale investment program to upgrade and expand the company's manufacturing complex. Total investment volume in 2010-2016 is be equal to more than 40 million of US dollars. The Company is in top - 5 biggest local pharmaceutical manufacturers by production volume and by realizing the investment programme intends to strengthen this position.


Manufacturing capacity
Location –Staraya Kupavna
20km from Moscow

Main facilities

  • 2 Dose-form finishing form facilities:1 for solids and 1 for soft-form and liquids
  • QC centre
  • R&D Pharma Labs
  • FG&RM warehouse complex
  • Customs Warehouse
  • Pharmaceutical Warehouse

Site Characteristics

  • Total property –36hectares
  • Total manufacturing area –20 500m2

In 2015 AKRIKHIN obtained its GMP certificate of quality compliance From Russian Ministry of Trade. Back in 1999 on Akrikhin production site together with Bristol-Myers Squibb Company production of cardio-vascular medicine was established which was the first in Russia to meet all requirements of GMP rules. Since that time Akrikhin successfully underwent more than 30 regular quality audits by quality assurance services of Akrikhin contract and license manufacturing business partners, Russian and overseas certification bodies, national regulatory authorities.


All the above achievements lead to attaining our goal – to ensure production of high-quality pharmaceutical products in compliance with national and international standards.